Atea Pharmaceuticals to Present at the Jefferies Healthcare Conference
05.06.2023 - BOSTON, June 05, 2023 (GLOBE NEWSWIRE) - Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today ...
Jonae Barnes Atea Pharmaceuticals Corporate Communications While The Company About Atea Private Securities Litigation Reform Act
Source: wallstreet-online.de